Methods of treatment using orodispersible desmopressin pharmaceutical formulations

US8802624B2 · kind B2 · utility

Assignee

• Ferring B.V. · NL

Inventors

• Anders Nilsson · Västerås, SE
• Hans Lindner · Leichlingen, DE
• Jørgen Wittendorff · Copenhagen, DK

Key dates

• Filing date: May 18, 2011
• Grant date: Aug 12, 2014
• Expiry date: Apr 16, 2032

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61K9/2095
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Described herein are methods of treating diseases or conditions such as incontinence, primary nocturnal enuresis (PNE), nocturia, and central diabetes insipidus, by administering desmopressin acetate in an orodispersiblc solid dosage form that disintegrates in the mouth within 10 seconds and includes an amount of desmopressin acetate, measured as the free base, of from 10 to 600 μg.